Publications

Pilati C, Amessou M, Bihl MP, Balabaud C, Van Nhieu JT, Paradis V, Nault JC, Izard T, Bioulac-Sage P, Couchy G et al..  2011.  Somatic mutations activating STAT3 in human inflammatory hepatocellular adenomas. Journal of Experimental Medicine. 208(668932323254529112661614395143715772267205211193251553):1359-1366. Abstract

Pelletier L, Rebouissou S, Paris A, Rathahao-Paris E, Perdu E, Bioulac-Sage P, Imbeaud S, Zucman-Rossi J.  2010.  Loss of hepatocyte nuclear factor 1alpha function in human hepatocellular adenomas leads to aberrant activation of signaling pathways involved in tumorigenesis. Hepatology. 51:557-66. Abstract

Rebouissou S, Amessou M, Couchy G, Poussin K, Imbeaud S, Pilati C, Izard T, Balabaud C, Bioulac-Sage P, Zucman-Rossi J.  2009.  Frequent in-frame somatic deletions activate gp130 in inflammatory hepatocellular tumours. Nature. 457:200-4. Abstract

Bioulac-Sage P, Laumonier H, Couchy G, Le Bail B, Sa Cunha A, Rullier A, Laurent C, Blanc JF, Cubel G, Trillaud H et al..  2009.  Hepatocellular adenoma management and phenotypic classification: The bordeaux experience. Hepatology. Abstract

Bioulac-Sage P, Laumonier H, Sa Cunha A, Balabaud C.  2009.  Hepatocellular adenomas. Liver Int. 29:142.

Villeneuve J, Pelluard-Nehme F, Combe C, Carles D, Chaponnier C, Ripoche J, Balabaud C, Bioulac-Sage P, Lepreux S.  2009.  Immunohistochemical study of the phenotypic change of the mesenchymal cells during portal tract maturation in normal and fibrous (ductal plate malformation) fetal liver. Comp Hepatol. 8:5. Abstract

Laumonier H, Bioulac-Sage P, Laurent C, Zucman-Rossi J, Balabaud C, Trillaud H.  2008.  Hepatocellular adenomas: magnetic resonance imaging features as a function of molecular pathological classification. Hepatology. 48:808-18. Abstract

Ladeiro Y, Couchy G, Balabaud C, Bioulac-Sage P, Pelletier L, Rebouissou S, Zucman-Rossi J.  2008.  MicroRNA profiling in hepatocellular tumors is associated with clinical features and oncogene/tumor suppressor gene mutations. Hepatology. 47:1955-63. Abstract

Rullier A, Gillibert-Duplantier J, Costet P, Cubel G, Haurie V, Petibois C, Taras D, Dugot-Senant N, Deleris G, Bioulac-Sage P et al..  2008.  Protease-activated receptor 1 knockout reduces experimentally induced liver fibrosis. Am J Physiol Gastrointest Liver Physiol. 294:G226-35. Abstract

Guyot C, Combe C, Balabaud C, Bioulac-Sage P, Desmouliere A.  2007.  Fibrogenic cell fate during fibrotic tissue remodelling observed in rat and human cultured liver slices. J Hepatol. 46:142-50. Abstract

Bioulac-Sage P, Blanc JF, Rebouissou S, Balabaud C, Zucman-Rossi J.  2007.  Genotype phenotype classification of hepatocellular adenoma. World J Gastroenterol. 13:2649-54. Abstract

Bioulac-Sage P, Rebouissou S, Thomas C, Blanc JF, Saric J, Sa Cunha A, Rullier A, Cubel G, Couchy G, Imbeaud S et al..  2007.  Hepatocellular adenoma subtype classification using molecular markers and immunohistochemistry. Hepatology. 46:740-8. Abstract

Rousseau B, Menard L, Haurie V, Taras D, Blanc JF, Moreau-Gaudry F, Metzler P, Hugues M, Boyault S, Lemiere S et al..  2007.  Overexpression and role of the ATPase and putative DNA helicase RuvB-like 2 in human hepatocellular carcinoma. Hepatology. 46:1108-18. Abstract

Gillibert-Duplantier J, Neaud V, Blanc JF, Bioulac-Sage P, Rosenbaum J.  2007.  Thrombin inhibits migration of human hepatic myofibroblasts. Am J Physiol Gastrointest Liver Physiol. 293:G128-36. Abstract

Boyault S, Rickman DS, de Reynies A, Balabaud C, Rebouissou S, Jeannot E, Herault A, Saric J, Belghiti J, Franco D et al..  2007.  Transcriptome classification of HCC is related to gene alterations and to new therapeutic targets. Hepatology. 45:42-52. Abstract

Rullier A, Senant N, Kisiel W, Bioulac-Sage P, Balabaud C, Le Bail B, Rosenbaum J.  2006.  Expression of protease-activated receptors and tissue factor in human liver. Virchows Arch. 448:46-51. Abstract

Zucman-Rossi J, Jeannot E, Nhieu JT, Scoazec JY, Guettier C, Rebouissou S, Bacq Y, Leteurtre E, Paradis V, Michalak S et al..  2006.  Genotype-phenotype correlation in hepatocellular adenoma: new classification and relationship with HCC. Hepatology. 43:515-24. Abstract

Rocha M, Avenaud P, Menard A, Le Bail B, Balabaud C, Bioulac-Sage P, de Magalhaes Queiroz DM, Megraud F.  2005.  Association of Helicobacter species with hepatitis C cirrhosis with or without hepatocellular carcinoma. Gut. 54:396-401. Abstract

Blanc JF, Lalanne C, Plomion C, Schmitter JM, Bathany K, Gion JM, Bioulac-Sage P, Balabaud C, Bonneu M, Rosenbaum J.  2005.  Proteomic analysis of differentially expressed proteins in hepatocellular carcinoma developed in patients with chronic viral hepatitis C. Proteomics. 5:3778-3789. Abstract

Lepreux S, Bioulac-Sage P, Gabbiani G, Sapin V, Housset C, Rosenbaum J, Balabaud C, Desmouliere A.  2004.  Cellular retinol-binding protein-1 expression in normal and fibrotic/cirrhotic human liver: different patterns of expression in hepatic stellate cells and (myo)fibroblast subpopulations. J Hepatol. 40:774-80. Abstract

Bacq Y, Jacquemin E, Balabaud C, Jeannot E, Scotto B, Branchereau S, Laurent C, Bourlier P, Pariente D, de Muret A et al..  2003.  Familial liver adenomatosis associated with hepatocyte nuclear factor 1alpha inactivation. Gastroenterology. 125:1470-5. Abstract

Avenaud P, Le Bail B, Mayo K, Marais A, Fawaz R, Bioulac-Sage P, Megraud F.  2003.  Natural history of Helicobacter hepaticus infection in conventional A/J mice, with special reference to liver involvement. Infect Immun. 71:3667-72. Abstract

Lamireau T, Dubuisson L, Lepreux S, Bioulac-Sage P, Fabre M, Rosenbaum J, Desmouliere A.  2002.  Abnormal hepatic expression of fibrillin-1 in children with cholestasis. Am J Surg Pathol. 26:637-46. Abstract

Guirouilh J, Le Bail B, Boussarie L, Balabaud C, Bioulac-Sage P, Desmouliere A, Schuppan D, Rosenbaum J.  2001.  Expression of hepatocyte growth factor in human hepatocellular carcinoma. J Hepatol. 34:78-83.. Abstract

Laurent-Puig P, Legoix P, Bluteau O, Belghiti J, Franco D, Binot F, Monges G, Thomas G, Bioulac-Sage P, Zucman-Rossi J.  2001.  Genetic alterations associated with hepatocellular carcinomas define distinct pathways of hepatocarcinogenesis. Gastroenterology. 120:1763-73.. Abstract